Manosphere obsession is linked to 18% higher risk of dying from cancer

Key Points:

• A recent study published in Lancet Healthy Longevity analyzed hormone data from over 26,000 men and found that very low testosterone levels are linked to an 18% higher risk of dying from cancer later in life.
• Cancer risk began to increase when testosterone levels dropped below 8.6 nanomoles per liter, though this association varied by cancer type and was not linked to prostate cancer mortality.
• Low levels of sex hormone-binding globulin (SHBG) and luteinizing hormone were associated with a higher risk of dying from prostate cancer, highlighting the complexity of hormone interactions and cancer risk.
• Researchers emphasize that low testosterone is likely a marker of other health issues rather than a direct cause of cancer, and there is no evidence that testosterone replacement therapy (TRT) reduces cancer risk.
• Despite these findings, the rise of "testmaxxing" and unregulated hormone use among men poses health risks, including fertility problems and potentially worsening existing cancers, underscoring the need for medical supervision.